Composite Defect Detection Now Meets Pharma-Grade Traceability

The aerospace composite supply chain has a precision problem that sounds familiar to anyone who has managed pharmaceutical batch records. A single undetected void or fiber misalignment in a carbon-fiber fuselage panel can propagate stress concentrations that remain dormant through certification testing, then fail catastrophically at 35,000 feet. The industry's response over the past eighteen months has converged on a strategy borrowed directly from regulated pharma manufacturing: real-time defect imaging paired with immutable digital provenance for every production unit. This is not aspirational manufacturing. It is already in pilot deployment at three tier-one aerospace suppliers, and the logistics are instructive for any operation managing high-consequence materials.